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Abstract
Background: Tandem repeats are multiple duplications of substrings in the DNA that occur contiguously, or at a
short distance, and may involve some mutations (such as substitutions, insertions, and deletions). Tandem repeats
have been extensively studied also for their association with the class of repeat expansion diseases (mostly
affecting the nervous system). Comparative studies on the output of different tools for finding tandem repeats
highlighted significant differences among the sets of detected tandem repeats, while many authors pointed up
how critical it is the right choice of parameters.
Results: In this paper we present TReaDS - Tandem Repeats Discovery Service,atandem repeat meta search engine.
TReaDS forwards user requests to several state of the art tools for finding tandem repeats and merges their
outcome into a single report, providing a global, synthetic, and comparative view of the results. In particular,
TReaDS allows the user to (i) simultaneously run different algorithms on the same data set, (ii) choose for each
algorithm a different setting of parameters, and (iii) obtain a report that can be downloaded for further, off-line,
investigations. We used TReaDS to investigate sequences associated with repeat expansion diseases.
Conclusions: By using the tool TReaDS we discover that, for 27 repeat expansion diseases out of a currently
known set of 29, long fuzzy tandem repeats are covering the expansion loci. Tests with control sets confirm the
specificity of this association. This finding suggests that long fuzzy tandem repeats can be a new class of cis-acting
elements involved in the mechanisms leading to the expansion instability.
We strongly believe that biologists can be interested in a tool that, not only gives them the possibility of using
multiple search algorithm at the same time, with the same effort exerted in using just one of the systems, but also
simplifies the burden of comparing and merging the results, thus expanding our capabilities in detecting
important phenomena related to tandem repeats.
Background
Overview on repeat expansion diseases
At present 29 diseases are classified as repeat expansion
diseases (RE) [1-3], and the number is growing. These
are mostly neurodegenerative and neuromuscolar disor-
ders, including Huntington disease (HD), Kennedy dis-
ease (SBMA), and several types of Spinocerebral Ataxias
(SCA). Since up to recently all known cases involved
repeating a motif of 3 nucleotides, this class was
denoted also as trinucleotide repeat (TNR) expansion
disease. However, cases of repeating units with 4, 5 and
12 nucleotides have been discovered thus we talk more
generally of repeat expansion diseases. Recent surveys
devoted to DNA repeats [4] have extended discussion of
repeat expansion disorders, while specific surveys for
repeat expansion diseases can be found in [5-7].
The locus of expansion can be located in various
regions of the resident gene: in the coding sequences, in
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lated region (3’-UTR), in introns and in promoter
regions. Two main questions are related to the study of
these diseases from a genetic point of view: (a) which
mechanisms or conditions lead to the repeat expansion?
and (b) how do repeat expansions result in diseases?
Only a small fraction of all the tandem repeats found
in the human genome expand and result in a disease.
Thus researchers have tried to identify which unusual
structural features favor such expansion, and found a
propensity to forming hairpins (or other structures, such
as: quadruplex-like structures, H-DNA and sticky DNA)
as a key mechanism leading to expansion. Several stu-
dies also tried to identify cis-regulating elements that do
favor the onset of the above structural features and of
the expansion. Our study falls in this category and pro-
poses long fuzzy tandem repeats as a novel cis-regulating
element for repeat expansion, thus contributing to
investigating question (a).
Cis-acting factors for TNR instability
Several papers tackle the problem of determining cis-acting
factors associated with loci of TNR instability. In particular
one quite studied factor is the proximity and orientation of
DNA replication initiation regions (IR) w.r.t. the TNR
instability locus [8,9]. In [8] the position of the DNA repli-
cation initiation region for three TNR diseases loci (HD,
SCA7, and SBMA) is analyzed, and a correlation pattern is
proposed. The role of flanking regions to the expansion
locus (EL) has been analyzed in literature. For example,
close proximity of the TNR locus to CpG-rich regions has
been noticed in some cases (10 diseases) [10]. The presence
of the transcription factor binding site (TFBS) CTCF has
been discovered in the flanking region for SCA7 [11]. An
association between HD and an haplogroup (with SNPs
not necessarily in the flanking sequences) is described in
[12]. Note that such studies identify cis-acting factors rele-
vant only for a few RE diseases.
Fuzzy tandem repeats (FTRs) have been recently pro-
posed as a new genomic feature worth of study [13,14].
Informally, FTRs are tandem repeats with high divergence
(30-40%) between the repeating units and the consensus
motif. At the best of our knowledge, up to now the hypoth-
esis that Fuzzy TRs can act as cis-elements for human dis-
eases was not explored in the literature. Interestingly we
have found FTRs in almost all the RE disease indepen-
dently from the specific repeating motif, coding/non-cod-
ing characterization, etc. Thus FTRs may be seen as a
“generic” cis-acting factor that may in particular cases
interact with other cis-acting factors specific for the single
protein/disease.
Analysis of TNR instability has been conducted also in
other model species, e.g. Saccaromyces cerevisiae [15]
and Escherichia Coli [16].
Role of hairpins
In several cases it has been noticed that the TNR RNA cod-
ing sequences tend to form hairpin structures [17-19] or
RNA-DNA hybrids such as R-loops [20]. This is relevant in
particular for the TNR located in the transcribed sections
of DNA. These results on hairpin are obtained via experi-
ments in vitro, usually involving a relatively short repeating
sequence (a trinucleotide unit repeated 16 or 17 times) and
a promoter sequence. In these experiments the role of the
native flanking regions is factored out or in some cases dif-
ferent (non-native) flanking sequences are used. Evidence
of hairpin formation with the natural flanking sequence for
SCA3, SCA6 and Dentatorubropallidoluysian atrophy
(DRPLA) is reported in [21]. Notice thus that, although
hairpin formation is an important mechanism to explain
trinucleotide instability, one cannot infer the presence of a
FTR just from the tendency to form hairpin (or other)
RNA structure in vitro. The relationship of FTR and hair-
pin formation is at the moment unclear and it is an open
area for future research, as in this stage we are interested in
establishing FTR as a potential cis-regulatory element,
rather than exploring the precise mechanisms of the action.
PolyQ repeats
For the subfamily of nine polyQ repeat diseases the cor-
responding polyglutammine peptide has been studied in
some detail [22,23]. Such studies are important for
determining the toxicity mechanism of the mutant pro-
teins, however they explain the onset of the disease only
after the expansion at the DNA locus occurs. In particu-
lar the pathogenic length of the polyQ chain is a specific
trait of each disease. A list of such diseases is reported
in table 1.
PolyA repeats
A second class of repeat expansion diseases involve repeti-
tions of the imperfect GCN triplets that encode the Ala-
nine amino acid. Such REs are characterized by relative
low copy numbers (both in the normal and expanded
states). In addition the expanded polyA repeats are stable
both in the somatic and intergenerational transmission,
unlike polyQ repeat expansions. A list of such diseases is
reported in table 2.
Non-polyQ and non-polyA repeats
Non-polyQ and non-polyA expanding repeats may have
motifs of length 3,4,5, and 12. They may be located in
several sections of the gene sequence. A list of such dis-
eases is reported in table 3.
Fuzzy tandem repeats as potential cis-regulatory
elements in repeat expansion disorders
In [14] we noticed that the locus associated with the
unstable trinucleotide repeat in the Frataxin protein
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cause of Frederich’s ataxia) was included in a much
longer fuzzy TR, detected using the proposed TRStalker
system.
The present research originated from the hypothesis
that this fact (a long fuzzy TR covering the unstable
locus) could be observed in a large number of trinucleo-
tide repeat disorders. Consequently, FTR could be
exposed as a novel cis-regulatory element not yet stu-
died in literature.
We employ the tool TReaDS in order to quickly col-
lect and organize the output of several TR finding algo-
rithms into a single easy to read report in support to
this hypothesis.
Tools for finding tandem repeats
Tandem repeats (TRs) of different forms (satellites,
microsatellites, minisatellites) have been studied exten-
sively because of their role in several biological pro-
cesses. In fact, TRs are privileged targets in activities
such as fingerprinting or tracing the evolution of popu-
lations [24,25]; several diseases, disorders and addictive
behaviors are linked to specific TRs loci [26]; the role of
TRs has been also studied within coding regions [27]
and in relation to gene functions [28].
The scope and depth of the research on TRs have
been boosted by the availability of efficient non-trivial
algorithms for finding TRs, even when mutations occur
with non-negligible probability. Tandem Repeat Finder
(TRF) [29], CRISPRFinder [30], mreps [31], Reputer
[32], Approximate Tandem Repeat Hunter (ATRHunter)
[33], TandemSWAN [13], and Tread [34] are some
examples of currently operational systems that can be
accessed via a web interface.
Comparative studies [13,35], for the case of short TRs
with high percentages of substitutions, report significant
differences among the sets of TRs that can be detected
by using different tools. Moreover, in [35] it is high-
lighted how critical it is the choice of parameters. Thus,
biologists could highly benefit from a tool that gives
them the possibility of simultaneously querying multiple
systems and getting a global, comparative and synthetic
view of the results, with the same effort one would exert
in using just one of the systems.
In this paper we present TReaDS - Tandem Repeats
Discovery Service,aTRs meta search engine that forwards
the user requests to different tandem repeat finding ser-
vices and aggregates the results. More in detail, TReaDS
allows the user to (i) simultaneously run different algo-
rithms on the same data set, (ii) choose manually, for
each algorithm, a different parameter settings, or express
her/his request in a simple and concise way (exact or
approximate, short or long TRs), delegating to TReaDS
the burden of choosing the right choice of parameters for
Table 2 Table of polyalanine diseases.
Disease code Disease name Gene code Normal repeats Pathogenic repeats
BPES Blepharophimosis-ptosis-epicanthus inversus syndactyly FOXL2 14 19-24
HPE5 Holoprosencephaly 5 ZIC2 15 25
CCHS Congenital failure of autonomic control PHOX2B 20 25-33
ISSX X-linked infantile spasm syndrome ARX 16 27
MRGH X-linked mental retardation with isolated growth hormone deficiency SOX3 15 22-26
CCD Cleidocranial dysplasia RUNX2 17 27
HFGS Hand-foot-genital syndrome HOXA13 18 24-26
SPD1 Synpolydactyly 1 HOXD13 15 22-29
OPMD Oculopharyngeal muscular dystrophy PABPN1 10 11-17
Table of polyalanine diseases. The table reports: disease code and full name, associated gene, ranges of healthy and pathogenic repeat numbers.
Table 1 Table of polyglutammine diseases.
Disease code Disease name Gene code Normal repeats Pathogenic repeats
DRPLA Dentatorubropallidoluysian atrophy ATN1 6 - 35 49 - 88
HD Huntington’s disease HTT (Huntingtin) 10 - 35 35+
SBMA Kennedy disease (Spinobulbar muscular atrophy) HS-AR 9 - 36 38 - 62
SCA1 Spinocerebellar ataxia Type 1 ATXN1 6 - 35 49 - 88
SCA2 Spinocerebellar ataxia Type 2 ATXN2 14 - 32 33 - 77
SCA6 Spinocerebellar ataxia Type 6 CACNA1A 4 - 18 21 - 30
SCA7 Spinocerebellar ataxia Type 7 ATXN7 7 - 17 38 - 120
SCA17 Spinocerebellar ataxia Type 17 TBP 25 - 42 47 - 63
SCA3 Machado-Joseph disease (Spinocerebellar ataxia Type 3) ATXN3 12 - 40 55 - 86
Table of polyglutammine diseases. The table reports: disease code and full name, associated gene, ranges of healthy and pathogenic repeat numbers.
Pellegrini et al. BMC Bioinformatics 2012, 13(Suppl 4):S3
http://www.biomedcentral.com/bmcbioinformatics/supplements/13/S4/S3
Page 3 of 15all the systems, and (iii) get back a report that can be
downloaded for further, off-line, investigations.
TReaDS is currently interfaced with five services based
on different algorithmic principles and techniques, thus
a joint use of them is likely to lead to increased preci-
sion. In order to improve the quality of service TReaDS
offers to its users, we plan to add to TReaDS other
existing systems and new ones at the time they become
available.
Methods
TReaDS is a web application, and it has been completely
developed by using Java-based technologies. In particular,
a pool of Servlets takes care of handling the users’
request (file upload, parameter settings, search), and col-
lects the results generated by the systems involved in the
query. TReaDS merges the results received from the
external services and produces the final report with the
support of the JasperReports publicly available libraries
[36] On the client side there is no special requirement:
just a standard browser and a viewer (suitable for the
report format selected by the user).
TReaDS has the proper structure of a meta search
engine, with options for changing the set of parameters
of each algorithm, and for choosing the output format.
The publicly available web tools for finding tandem
repeats currently supported by TReaDS are: ATRHunter
[37] mreps [38] TandemSWAN [39] and TRF [40].
TReaDS is interfaced with the version of these tools
available on-line. Note that a binary version of these sys-
tems can be also downloaded and, in some cases, there
are some small differences between the web-based and
the downloadable versions, especially in terms of the
number of parameters that can be customized. Further-
more TReaDS supports TRStalker [14], an algorithm
developed by our team aimed at finding long fuzzy TRs
under weighted edit distance.
TReaDS input/output
The main page of TReaDS is essentially composed of
four sections: (1) Algorithms,( 2 )Parameter Settings,( 3 )
Report, and (4) Sequence (see Figure 1).
In the Algorithms section it is possible to choose any
combination of the supported systems.
In the Parameter setting section TReaDS provides
two ways to set the parameters for the chosen systems:
(i)t h esimple mode, where it is possible to specify the
kind of TRs to look for, by setting the minimum and
maximum motif length, the minimum exponent (i.e.
the number of repetitions), and the maximum percen-
tages of allowed substitutions and in/dels (insertions
and deletions); (ii)t h eadvanced mode,w h e r et h eu s e r
can run each system with manually selected para-
meters, if she wants a fine-grained control over the
settings.
In the Report section the user:
1. decides if she wants in the final report a graphical
visualization of the found TRs;
2. chooses if the input sequence (or a part of it)
must be included into the final report;
3. sets the length of the flanking sequence; and
4. chooses the final report format among the avail-
able ones: HTML, Excel, PDF, and RTF.
In the Sequence section it is possible to submit a
sequence as a file, or to paste it in a given text area;
furthermore the user can chose if the whole sequence or
j u s tap a r to fi tm u s tb ea n a l y z e d .TReaDS takes as input
either a FASTA or plain text genomic sequence. The size
limit for an input sequence corresponds to the present
limit of ATRHunter: 2Mbp.
The user can decide to wait on-line for the result or
to receive them via email by providing a valid email
address.
Table 3 Table of non-polyglutammine, non-polyalanine diseases.
Disease code Disease name Gene Motif Location Normal repeats Pathogenic repeats
FRAXA Fragile X syndrome FMR1 CGG 5’-UTR 6 - 53 230+
FXTAS Fragile Xassociated tremor/ataxia syndrome FMR1 CGG 5’-UTR 6 - 53 55-200
FRAXE Fragile XE mental retardation AFF2 GCC 5’-UTR 6 - 35 200+
FRDA Friedreich’s ataxia FXN GAA Intr. 7 - 34 100+
DM1 Myotonic dystrophy type DMPK CTG 3’-UTR 5 - 37 50+
DM2 Myotonic dystrophy type 2 ZNF9 CCTG Intr. 27- 75+
SCA10 Spinocerebellar ataxia Type 10 ATXN10 ATTCT Intr. 10-29 280+
SCA12 Spinocerebellar ataxia Type 12 PPP2R2B CAG 5’-UTR 7 - 28 66 - 78
EPM1 Progressive myoclonus epilipsy CSTB (C)4G(C)4GCG Prom. 2-3 60+
HDL-2 Huntington diesease-like JPH3 CAG/CTG 3’-UTR 66- 66+
SCA8 Spinocerebellar ataxia Type 8 ATXN8OS CTG 3’-UTR 16 - 37 110 - 250
Table of non-polyglutammine and non-polyalanine diseases. The table reports: disease code and full name, associated gene, repeating unit genic region, ranges
of healthy and pathogenic repeat numbers.
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Page 4 of 15Figure 1 TReaDS: main page of the graphics user interface. The main page of the graphics user interface allows setting the input
parameters. This page has sub-sections for: algorithms selection, parameters of the tandem repeats to be reported, style of the output report,
and input sequence.
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vices have been received, TReaDS merges the results
and produces a report containing the following sub-
reports:
￿ Sequence sub-report. The sequence sub-report
contains the sequence, if requested, and some infor-
mation such as length and distribution of the differ-
ent bases (see Figure 2).
￿ Summary sub-report.T h es u m m a r ys u b - r e p o r t
contains, for each system involved in the query, the
algorithm name, the number of TRs found, whether
the connection has been successful (if not, the type of
error encountered is reported), and the response time.
It is also provided a chart that shows a comparison of
the systems (the comparison is simply based on the
number of TRs found) (see Figure 3).
￿ Algorithm sub-reports. There is one algorithm
sub-report for each system included in the search
process (see, for instance, Figure 2). It contains the
detail of the parameters used and the list of the TRs
found by the specific algorithm, including their initial
position, length, number of repetitions, and consen-
sus. In case of advanced mode search the parameters
are those the user set for the given algorithm, while
in case of simple mode search the global parameters
given as input are reported (see Figure 4).
￿ Clusters sub-report. TReaDS merges the results of
all algorithms to give a global view of them by iden-
tifying overlapping TRs. Two TRs overlap if they
share one or more positions in the sequence. The
overlapping relation is an equivalence relation thus
it allows us to partition the found TRs into groups
that we call clusters. Such clusters are reported in
the clusters sub-report (see Figure 5). Graphically, a
cluster covers a contiguous segment of the input
sequence without gaps. The report contains a list of
all clusters found. For each cluster the following
information is included: flanking sequence (if
requested), starting and ending positions of the cov-
ered segment, list of TRs that form the cluster, and
some details for each TR (starting and ending posi-
tion, length, number of repetitions, consensus). If
the user has chosen to include the images in the
final report, it is also possible to view each cluster in
a graphical form (see Figure 6).
Results
Experimental methodology
The relevant sequences have been downloaded from
PubMed (See NCBI codes in Additional file 1) and the
position of the expansion locus identified via reference
to the relevant literature for the target disease. For
sequences up to 10000 nt the whole sequence has
been analyzed. For longer sequences a sub-sequence in
the range -5000 +5000 nt centered on the expansion
locus has been analyzed. The tool TReaDS has been
set with 5 algorithms; the parameter setting is reported
in table 4.
Figure 2 TReaDS: example of the sequence sub-report. The sequence sub-report of the output report gives basic statistics on the nucleotide
frequencies of the input sequence and the total length of the clusters of tandem repeats reported.
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returned it is possible to identify the longest TR cover-
ing the expansion locus. In a second phase, for each
analyzed sequence, the algorithm that found a covering
FTR has been tuned so to possibly find a better fuzzy
TR (with a longer motif, and lower error level), while
minimizing the measure of the union of fuzzy TRs of
the same type in that sequence.
In most cases a single covering FTR has been found.
In one case (SCA10) two partially overlapping FTRs
cover the expansion locus. The FTRs found have copy
number roughly between 2 and 3 in most cases. In
principle, a FTR containing an EL may arise from a
large self-overlapping of the EL segment in the FTR.
Thus we need to show that such self-overlapping does
not influence our data. Simple consideration based on
t h er a t i oo ft h el e n g t h so ft h eF T Ra n dE Ls e g m e n t s
imply that no self-overlapping can occur when the
ratio is greater or equal to 2. For a ratio 1.8 at most
t h eo v e r l a pc a nb eo ft h eo r d e ro f1 0 %o ft h el e n g t ho f
the EL.
We also measure the total length of the regions of
the sequence covered by FTR of the same type (same
motif length or longer, and same percentage of error)
as the one identified as covering the expansion locus.
The ratio of this length and the length of the sequence
gives a conservative estimate to the probability that a
randomly chosen position in the sequence is covered
by a FTR of the type considered. The value of such
probability is quite small for almost all of the
sequences, resulting in an average probability over all
the sequences associated to repeat expansion diseases
of 0.12.
Experiments with repeat expansion sequences
The list of the major diseases due to repeat expansion
are taken from [2,3].
An important subfamily is composed of polyglutam-
mine diseases (polyQ) since the repeated triplet motif
is the codon CAG, in a coding region, that encodes
the glutamine (Q) amino acid (see table 1 and 5). A
second subfamily is the family of polyanaline (polyA)
expansion disease, where the expanding motif is
formed by triplets GCN (see table 2 and 6). Other dis-
eases are classified as non-polyQ and non-polyA and
are listed in tables 3 and 7.
Specificity of fuzzy tandem repeats for genes with CAG-
encoded polyglutammine
In order to test the specificity of the association of cov-
ering fuzzy TRs with repeat expansion loci we have ana-
lyzed a sample of genes with long CAG-encoded
polyglutammine (more than 6 repeating units). We have
chosen this subclass since it has been extensively studied
in literature. The statistics for this type of repeats have
been collected in [6] that lists 148 sequences in ORF
regions (out of a total of 718), and [41] listing 64 polyQ
genes. We have examined the first 25 entries of the list
Figure 3 TReaDS: example of the summary sub-report. The summary sub-report of the output report gives the termination codes for each
algorithm and basic statistics on the number of tandem repeats detected by each algorithm.
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more present in NCBI Nucleotide databases have been
replaced by the newer version of the same gene when
possible; entries for the same gene have been merged.
Thus we have examined a total of 17 sequences in
tables 8 and 9.
Four sequences have been investigated in literature for
their potential role in diseases (table 8).
Polymorphism of the the CAG repeat in protein RAI1
has been found to influence the onset age in patient
affected by the spinocerebellar ataxia type 2 (SCA2)
[42]. Data shown in [43,44] indicate a genetic linkage of
Figure 4 TReaDS: example of an algorithm sub-report. The algorithm sub-report of the output report lists separately the tandem repeats
found by each algorithm and their basic features.
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with many developmental disorders affecting limbs, kid-
neys, eyes, and ears, although specific causality and
mechanisms still need to be elucidated. The gene
MAML3 is shortlisted in [45] for further study in dis-
ease associations, based on comparing the conservation
patterns among human, mouse and rat genomes. The
human neuregulin-2 (NRG2) gene has been evaluated
Figure 5 Example of a cluster returned by TReaDS. The clusters sub-report of the output report lists all tandem repeats organized in clusters
of overlapping tandem repeats. For each cluster its beginning and end positions are reported, and the constituent tandem repeats.
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disease [46]. Since the pathogenic status of these repeats
is still unclear we exclude them from further analysis.
For the remaining 13 sequences (table 9) we have
found evidence of a covering Fuzzy TR in 2 cases (15%).
Specificity of fuzzy tandem repeats for genes with
pathological SNPs
In this section we explore the issue of the specificity of
FTR covering mutation loci linked to pathological
Figure 6 A cluster returned in graphical format. Example of a cluster returned by TReaDS: the cluster is showed in a graphical format, with
the original sequence opportunely underlined in the position of the found TR, and with different colors, each corresponding to the particular
queried algorithm returning the TR.
Table 4 Parameters for TReaDS used in the experiments.
Parameter name Value
Minimum motif length 10
Maximum motif length unlimited
Minimum repeat number 2
Maximum substitution 20%
Maximum indel 20%
Parameters for TReaDS used in the experiments..
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the first one is due to single nucleotide substitutions
(SNP). The data base dbSNP (Human Build 135) [47,48]
lists as of today, 1835 records of pathogenic SNPs for
Homo Sapiens sequences. We have selected a sample
(See Additional file 1) of such sequences and analyzed
them using TReaDS. Results reported in table 10 show
that out of 43 pathogenic SNPs in 14 sequences, only 2
are covered by a long FTR (14%).
Specificity of fuzzy tandem repeats for genes with
pathological in/dels
T h ed a t ab a s ed b S N P( H u m a nB u i l d1 3 5 )l i s t s ,a so f
today, 391 records of pathogenic short in/dels for
sequences of Homo Sapiens. We have selected a sample
of such sequences (See Additional file 1) and analyzed
them using TReaDS. Data in table 11 show that for 67
pathogenic in/dels only 9 are covered by FTR (13%).
Conclusions
Results on repeat expansion diseases
We have found that for the current set of 29 repeat
expansion diseases in 27 cases (93%) there is a long
fuzzy TR covering the expansion locus. The ratio of the
length of the fuzzy TR to the expansion locus ranges
from a minimum of 1.608 and a maximum of 15.194.
Also the specificity of the association has been investi-
gated for the set of genes with CAG-encoded polyglu-
tammine tracts, for pathogenic SNPs, for pathogenic in/
dels, and for the non-pathogenic sections of the
sequences. This specificity analysis shows that in just
about 15% of the control cases there is an association to
fuzzy TRs. These preliminary results indicate that fuzzy
TRs may be an important novel cis-element that influ-
ences the instability of the expansion locus. However, a
more in depth analysis and consideration of causal
mechanisms involved is needed to confirm the correla-
tion between fuzzy TRs and RE diseases.
The power of TReaDS
As large scale studies are being pursued, it is important
to facilitate the use of the TR search engines publicly
available. In the literature, the comparison of several TR
finding tools highlighted significant differences among
the sets of results. Other work made evident the impor-
tance of tuning the parameters of operation. In this
paper we presented TReaDS,aw e ba p p l i c a t i o nw h i c h
provides a single user interface and enables a
Table 5 Table of fuzzy tandem repeats for PolQ TR.
Gene code Seq length Cover TR-beg TR-end FTR-beg FTR-end FTR/TR Cover/Length
ATN1 4367 206 1687 1743 1646 1751 1.875 0.047
HTT 13481 196 197 265 196 367 2.514 0.014
HS-AR 4314 377 1286 1354 1224 1391 2.455 0.087
ATXN1 10636 4237 1560 1646 1500 1718 2.534 0.398
ATXN2 4712 401 658 726 629 748 1.75 0.085
CACNA1A 8641 579 7186 7224 7160 7425 6.973 0.067
ATXN7 7242 443 641 670 576 743 5.758 0.061
TBP 1921 305 451 564 389 636 2.185 0.158
ATXN3 10000(*) - 943 984 - - - -
Table of fuzzy tandem repeats for PolQ TR. The table reports: gene code, sequence length, length of the region covered by FTRs, TR expansion begin and TR
expansion end, FTR begin and FTR end, ratio of FTR length over TR length, ratio of region covered by FTRs over total sequence length. (*) indicates that a
subsequence has been analyzed.
Table 6 Table of covering fuzzy tandem repeats for polyalanine TR.
Gene code Seq length Cover TR-beg TR-end FTR-beg FTR-end FTR/TR Cover/Length
FOXL2 9900 5000 6079 6115 6082 6258 4.888 0.505
ZIC2 11701 677 8385 8429 8304 8534 5.227 0.057
PHOX2B 11889 187 7940 7993 7830 8015 3.490 0.015
ARX 19255 1039 7252 7299 7199 7424 4.787 0.053
SOX3 9074 1114 5700 5744 5584 6191 13.795 0.122
RUNX2 10000 (*) 766 99435 99485 99310 99488 3.560 0.076
HOXA13 10227 658 5375 5428 5328 5493 3.113 0.064
HOXD13 10135 279 5256 5300 5025 5304 6.340 0.027
PABPN1 12976 1337 6286 6303 6278 6405 7.470 0.103
Table of covering fuzzy tandem repeats for polyalanine TR. The table reports: gene code, sequence length, length of the region covered by FTRs, TR expansion
begin and TR expansion end, FTR begin and FTR end, ratio of FTR length over TR length, ratio of region covered by FTRs over total sequence length. (*) indicates
that a subsequence has been analyzed.
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Page 11 of 15simultaneous application of different techniques on the
same data set. With TReaDS the user can express the
characteristics of her request through a simple and uni-
fied interface, or she can customize the set of para-
meters of each system. The user gets back a report that
contains a global and comparative view of the results.
The report can be downloaded for a deeper off-line
investigation. This way, TReaDS allows to harness the
power of different web-based TR search engines with a
minimal effort.
Furthermore, merging and comparing the outcome of
different search tools on the same data can be useful for
gaining higher confidence that all the relevant TRs in
the data set have been found.
To the best of our knowledge TReaDS is the first meta
search engine for tandem repeats and there is no similar
and comparable system freely available.
Future work
The database TRbase [49] maintains an annotated cor-
respondence between genes known to be involved in
some disease and the tandem repeats in their DNA
sequence (detected with TRF [29]). For the class of
repeat expansion diseases a direct causal link between
T R sa n dt h eo n s e to ft h ed i s e a s ei sk n o w n .A sf u t u r e
work we plan to analyze the correlation between other
diseases (or disease classes) and the presence and type
of fuzzy TRs, using TReaDS,i no r d e rt os u g g e s t
hypothesis on possible roles for fuzzy TRs in that
context.
In this paper we studied those trinucleotide expan-
sion (and repeat expansion) leading to the manifesta-
tion of diseases. However, polymorphic microsatellites
and ministatellites are very common in the human
genome (as well as in all eukaryote genomes), thus one
could advance the hypothesis that FTR may have a
facilitating role in such polymorphisms (independently
from the manifestation of a pathology). Testing this
Table 7 Table of covering fuzzy tandem repeats for non-polyglutammine and non-polyalanine TR.
Gene code Seq length Cover TR-beg TR-end FTR-beg FTR-end FTR/TR Cover/Length
FMR1 46137 3415 5061 5171 4983 5168 1.681 0.074
AFF2 16800 595 5021 5062 4958 5429 11.487 0.035
FXN 2465 723 2185 2212 2036 2414 14.000 0.293
DMPK 2465 273 2304 2363 2213 2365 2.576 0.110
ZNF9 23153 5462 16312 16387 16264 17088 10.986 0.235
ATXN10(**) 50000(*) 1301 128559 128628 28543 28654 1.608 0.026
PPP2R2B 5120 703 2088 2366 1842 2363 1.874 0.137
CSTB 9429 3098 4899 4935 4472 5019 15.194 0.328
JPH3 10000(*) 807 35581 35746 35476 35755 1.690 0.080
ATXN8OS 39541 - 37142 37216 - - - -
Table of covering fuzzy tandem repeats for non-polyglutammine and non-polyalanine TR. The table reports: gene code, sequence length, length of the region
covered by FTRs, TR expansion begin and TR expansion end, FTR begin and FTR end, ratio of FTR length over TR length, ratio of region covered by FTRs over
total sequence length. (*) indicates that a subsequence has been analyzed. (**) indicates two overlapping FTRs.
Table 8 Table of covering fuzzy tandem repeats for a
sample of CAG-encoded polyglutammine that have been
investigated for possible connections to pathologies.
Gene code Tri-repeat position FTR position References
RAI1 1300+39 1290-1368 [41,42]
DACH1 846+42 830-926 [43,44]
(TNRC3) MAML3 2220+36, 2187-2292, [41,45]
2667+24, 2628-2698,
3030+24 2960-3053
NRG2 302+18, 329+24 227-401 [46,52]
Table of covering fuzzy tandem repeats for a sample of CAG-encoded
polyglutammine that have been investigated for possible connection to
pathologies. The table reports: gene code, location of the polyQ locus,
location of the fuzzy TR if existing, relevant references.
Table 9 Table of covering fuzzy tandem repeats for a
sample of CAG-encoded polyglutammine.
Gene code Tri-repeat
position
FTR position References
NFAT5 1497+18 - [41]
vascular endothelial
cadherin 2
4739+18 -
PRDM8 1865+18 -
PRDM10 3327+27 - [41]
ATBF1-A 10262+21 -
USP7 208+21 -
IRS1 2049+18 -
(ATBF1) ZFHX3 10262+21 -
FBX11 90+21 -
PCQAP 611+18,
711+18,
831+36
607-652,
712-869
[41]
(DRIL2) ARID3B 214+24 -
POU3F2 594+18 516-618 [41]
PALM2-AKAP2 1738+18 -
Table of covering fuzzy tandem repeats for a sample of CAG-encoded
polyglutammine. The table reports: gene code, location of the polyQ locus,
location of the fuzzy TR if existing, relevant references.
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Page 12 of 15far-reaching hypothesis which is our next objective, is
far from trivial since comprehensive maps of poly-
morphic/monomorphics TRs for the human genome,
(even restricted the coding regions) are just being pro-
duced [50,51].
Availability and requirements
￿ Project name: TReaDS
￿ Project home page: http://bioalgo.iit.cnr.it/treads
￿ Operating system(s): Platform independent
￿ Programming language: Java
￿ Other requirements: JavaScripts Enabled (on the
client side)
￿ License: Lesser General Public License (LGPL)
￿ Any restrictions to use by non-academics: None,
TReaDS is a web application free and open to all
users
Additional material
Additional file 1: “Tandem repeats discovery service (TReaDS)
applied to finding novel cis-acting factors in repeat expansion
diseases - supplementary information –” contains NCBI codes of
analyzed sequences and dbSNP codes for the analyzed SNPs and
in/dels.
List of abbreviations
DRPLA: Dentatorubropallidoluysian atrophy; EL: Expansion locus; FTR: Fuzzy
tandem repeats; HD: Huntington disease; IR: Initiation region; polyA:
polyalanine; polyQ: polyglutammine; RE: Repeat expansion; SCA: Spinocerebral
ataxia; TFBS: Transcription factor binding site; TNR: Trinucleotide repeat; TR:
Tandem repeat; TReaDS: Tandem repeats discovery service.
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Table 10 Table of pathogenic SNPs in Homo sapiens from dbSNP and covering fuzzy tandem repeats.
Gene/Protein Seq length Num. path. SNP Covered by FTR FTR
FZD6 3806 2 0 -
NSDHL 1581 2 0 -
GJB1 1623 10 0 -
IDS 1437 5 0 -
IDS 5832 2 0 -
SLC16A2 4396 2 0 -
NSDHL 1581 2 0 -
ABCB7 2404 2 0 -
TIMM8A 1459 2 0 -
UBA1 3544 3 0 -
FLNA 8533 2 2 [1000- 3946]
MED12 6985 1 0 -
PRPS1 2156 4 0 -
ARSE 2220 4 0 -
Table of pathogenic SNPs in Homo sapiens from dbSNP and covering fuzzy tandem repeats. The table reports: gene/protein code, sequence length, number of
pathogenic SNP, number of pathogenic SNPs covered by FTR, FTR [Begin - End] if existing.
Table 11 Table of pathogenic in/dels in Homo sapiens from dbSNP and covering fuzzy tandem repeats.
Gene/Protein Seq length Num. path. in/dels Covered by FTR FTR
CFTR/MRP 1000 (*) 2 0 -
OTC 1000 (*) 3 2 [117 - 883], [429 - 569]
OTC 1647 30 0 -
HS mitochondrion 16569 1 0 -
NSDHL 1581 2 0 -
GJB1 1623 2 1 [319-373]
SLC16A2 4396 2 0 -
SLC6A8 3580 2 0 -
CACNA1F 6080 1 0 -
FLNA 8533 1 1 [280 329]
KCNQ2 3158 21 5 [162-275] [1666-1691]
[2188-2214] [2654-2728]
Table of pathogenic in/dels in Homo sapiens from dbSNP and covering fuzzy tandem repeats. The table reports: gene/protein code, NCBI code for the analyzed
sequence, sequence length, codes of pathogenic in/del, number of pathogenic in/dels covered by FTR, FTR [Begin - End] if existing. (*) indicates that the analysis
has been done on a subsequence of length 1000 centered on the position of each in/del.
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